B.Riley on Ovid Therapeutics Inc (OVID): 'one of our top picks from last week's B. Riley MMV Summit'
Tweet Send to a Friend
B.Riley analyst Madison El-Saadi reiterated a Buy rating and $5.00 price target on Ovid Therapeutics Inc (NASDAQ: OVID).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
